Procalcitonin levels as a predictor of recovery in hospitalized infections
Part of Infections clinical trials.
This study looks at whether a blood test called procalcitonin, which measures inflammation, can help predict how well patients with infections will recover while in the hospital. It may help doctors better understand your condition and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized with an acute (sudden) infection
- You had a procalcitonin blood test during this hospital stay (as of 2020 or later)
- You are 18 years or older
- You do not have certain conditions that can falsely raise procalcitonin, such as recent major surgery, severe burns, major trauma, severe pancreatitis, cardiogenic shock, or certain cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a blood test called procalcitonin to decide when to start antibiotics in critically ill patients with a new infection. The goal is to reduce unnecessary antibiotic use while still effectively treating infections.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
This trial tests whether using a blood test called procalcitonin (which measures infection levels) can help doctors decide when to start and stop antibiotics for a lower respiratory tract infection (like pneumonia or bronchitis). The goal is to see if this approach works as well as the standard way of prescribing antibiotics.
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
This trial tests whether measuring procalcitonin or zinc in the blood is better at diagnosing pneumonia that develops in patients on breathing machines in the intensive care unit. The results could help doctors choose the right treatment faster.
This study is checking if a blood test for procalcitonin (a sign of infection) can help measure how severe bronchiectasis is in children. It aims to find a way to better understand and manage this lung condition.
Hear when a new Procalcitonin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.